🐻 AXTI $1.2M Far-OTM Tail-Fade Put — Is the 30x AI-Optics Rally Running Out of Road?

📅 June 26, 2026 | 🔥 Unusual Activity Detected

✅ Updated June 29, 2026 (morning OI check): Next-day OPRA OI ROSE 693 → 20,510 (Δ +19,817), confirming this as an opening BTO. The read below holds — no inversion. See the ✅ RESOLVED box.

---

🎯 The Quick Take

Someone just dropped $1.2 million on deeply out-of-the-money AXTI puts expiring in just 6 days — betting that a stock that has re-rated more than 30x in a year could gap violently lower before July 2nd. With AXT Inc trading around $67.48 at the time of the trade and the $40 strike sitting ≈40% below spot, this is not a high-probability directional bet — it is a cheap, short-dated lottery ticket or crash hedge on one of the most volatile small-caps in the market right now.

---

📊 Company Overview

AXT Inc (NASDAQ: AXTI) makes the unglamorous but essential raw materials powering the AI-optics boom:

• 🏭 What they do: Compound semiconductor substrates — indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge) wafers — that sit at the foundation of the high-speed lasers and optical transceivers routing data through AI datacenters
• 💰 Market Cap: ≈$4.4B (stockanalysis.com)
• 🏷️ Sector: Electronic & Other Electrical Equipment (compound semiconductors)
• 📈 52-Week Range: $1.85 – $143.16 — NO reverse split. This is an organic 30x+ re-rating driven by genuine AI-optics demand, a record >$100M InP backlog, and an April 2026 $632.5M capital raise at $64.25/share to fund an InP capacity doubling. The stock now consolidates in the $66–$70 zone after peaking near $143 intraday.
• ⚡ Why so volatile: Daily moves of ±12–19% have been routine in June 2026. Revenue is gated by opaque China Ministry of Commerce InP export permits on a ≈60-business-day cadence — a binary that can gap the stock in either direction with almost no warning.

---

💰 The Option Flow Breakdown

📊 What Just Happened

Someone bought 20,000 far-out-of-the-money AXTI puts at 10:59 AM this morning, paying $0.62 per contract for a total net premium of $1.2 million:

Key facts at a glance:

• 🎯 Strike distance: $40 is ≈40% below the $67.48 spot — deeply, deeply out of the money
• ⏰ Time to expiry: 6 days (expires July 2, 2026)
• 📈 Aggression: Printed above the ask — this buyer was willing to pay up to get filled immediately
• 🔁 Mechanism: Single-leg auction — a facilitated execution where a broker routed a large order through a price-improvement process. The auction mechanism means this was not a panic sweep of the open book, but it was still an aggressive buy above the prevailing offer
• 🚫 No stock block on the equity tape — this is a pure options-only directional/tail bet, no delta-hedge paired with it

---

✅ RESOLVED — Next-Day OPRA OI Confirms an OPENING BUY (BTO)

The June 29 pre-market OPRA snapshot (reflecting June 26 end-of-day) is in. Open interest ROSE — confirming this as a fresh opening buy, not a close.

Leg	Baseline OI (pre-print)	Resolving OI (next-day)	Δ	Trade Size	Verdict
$40 put exp 2026-07-02	693	20,510	+19,817	19,979	✅ OPEN (BTO)

OI rose by +19,817 vs the 19,979-contract print, confirming a fresh opening buy (BTO long puts). The conviction read below holds — no inversion.

With 19,979 contracts printed against prior open interest of just 693, this is a size-proven fresh open: the raw size mathematically requires the vast majority of these contracts to be newly created. The next-day OPRA snapshot has now confirmed it — OI rose 693 → 20,510 (Δ +19,817).

---

🤓 What This Actually Means — Plain English

Let's be real about what this trade is and what it isn't.

What it IS:

This is a far-OTM, short-dated tail bet or crash hedge — the options equivalent of buying lottery tickets on a black-swan event. Here's the math on why:

• 🎰 The $40 strike is ≈40% below where AXTI was trading when this printed ($67.48)
• ⏰ There are only 6 days left until expiration on July 2
• 💸 The buyer paid $0.62 per contract × 20,000 contracts × 100 shares = $1.24M total outlay
• 💀 This option expires worthless unless AXTI falls more than 40% in the next 6 days — that is an extraordinary move by any standard

So why would anyone buy this? Two main interpretations:

1. Crash hedge / tail protection. Somebody holds a large long position in AXTI (stock, calls, or a broader AI-optics basket) and wants cheap insurance against a catastrophic gap-down. The China MOFCOM InP export-permit regime has already forced a ≈20% guidance cut once (Q4 2025 cut from $27–30M to $22.5–23.5M). A bad permit batch or a geopolitical headline could, in theory, gap the stock hard. At $0.62 per contract, $1.2M buys a huge notional hedge for pennies on the dollar.

2. Momentum-fade lottery ticket. AXTI ran from ≈$1.85 to ≈$143 in under a year, then faded back to the mid-$60s. The pattern of buying cheap far-OTM puts on parabolic momentum names after a big fade is a classic "if this thing cracks for real, I want to be there" bet. The buyer is essentially saying: "I'll spend $1.2M for a chance to make 10x+ if this AI-hype story completely unravels before July 2."

What it is NOT:

• ❌ A high-probability directional call — the overwhelming statistical reality is that a 40%-OTM 6-DTE put expires worthless
• ❌ Evidence that someone "knows" a crash is coming — the OPRA tape cannot tell us the buyer's identity, their existing positions, or their information source
• ❌ A traditional institutional hedge with precision — institutions hedging a real long position typically use closer-to-the-money, longer-dated puts

Why is IV so high on AXTI?

The options market is pricing in extreme uncertainty for good reason:

• 📊 Daily moves of ±12–19% have been common in June 2026 — the stock dropped ≈10% in a single session on June 26 (to ≈$66.72) before recovering (Investing.com)
• 🇨🇳 The China MOFCOM export-permit binary means each quarter's revenue is partly a coin-flip on bureaucratic timing
• 📅 Q2 2026 earnings on July 30, 2026 (after this put expires) set up a confirmed event-vol bid
• 📈 A ≈3:1 put:call skew on heavy options volume reflects aggressive two-sided hedging and speculation (Fintel)
• 💰 The April 2026 $632.5M share issuance added substantial float the market is still digesting

Bottom line in plain English: someone spent $1.2M to buy far-OTM insurance or a long-shot fade bet on a stock that has already shown it can move ±40% in a matter of weeks. These puts almost certainly expire worthless — but if AXTI cracks hard, the payout is enormous.

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

The YTD chart for AXTI tells one of the most extreme stories in the 2026 market: from ≈$2 to ≈$143 on the AI-optics / indium-phosphide demand wave, then a sharp fade back toward $67. As of June 26, AXTI is down roughly 50% from its all-time high, but still up an extraordinary multiple from its 52-week low of $1.85.

Key observations:

• 🚀 The re-rating was real: InP substrates became the hot upstream input for AI-datacenter optical transceivers, and AXT is one of the few merchant suppliers. The record $100M+ backlog and a >50% InP revenue mix in Q1 2026 validated the move
• 😰 The fade from $143 is real too: A 50%+ drawdown from the high while the thesis is still intact shows how sentiment-driven and momentum-driven this name is
• 🎢 Volatility is extreme and structural: ±12–19% daily moves make this one of the most volatile large-cap-sized names in the market
• 📊 Consolidation zone: The $66–$70 area appears to be the current digestion range, with the April equity raise at $64.25 acting as a soft psychological floor

Gamma-Based Support & Resistance Analysis

A note on gamma data: AXTI's gamma exposure map is thin — this is a small-cap name with a relatively short listed-options history at these price levels, so the gamma bars are modest compared to mega-caps. Do not lean on the gamma data as a primary navigation tool here; use it as a rough guide and weight the implied-move ranges more heavily.

That said, the data reveals one dominant feature:

🟠 Call Gamma / Resistance Above Price:

• $70 — The single largest total gamma level (1.763 total GEX), sitting just pennies above the June 26 trade-time spot of $67.48. This is the nearest ceiling; the options market has the most activity concentrated here. A sustained close above $70 would be a notable breakout signal.
• $75, $80 — Secondary resistance at 0.515 and 0.749 total GEX respectively — moderate overhead supply

🔵 Put Gamma / Support Below Price:

• $65 — Nearest meaningful put gamma level (0.520 total GEX, with the largest put-dominated net GEX reading of −0.366 among nearby strikes). This is the immediate floor to watch.
• $60 — Secondary support (0.223 total GEX), net put-dominated
• $55, $50 — Lighter gamma support in the $50–$55 zone; below $50 the gamma gets very thin
• $40 — This is where the trade is struck. The GEX data shows minor put gamma activity here (total GEX 0.326), consistent with it being a lightly-traded far-OTM level before today's 20,000-contract print. After today's open interest builds, this level may develop more gravitational significance on the downside.

What this means: The gamma map confirms $70 as the near-term ceiling and $65 as the first line of support. For the $40 put to pay off, the stock would need to blow through four or five support levels in 6 days — which is why these puts cost $0.62 and not $6.20.

Implied Move Analysis

This is where things get interesting. The options market is pricing extraordinary uncertainty into AXTI:

Translation for regular folks:

The options market says AXTI could trade anywhere from $57 to $83 by July 2 — an ±18.5% swing that reflects the stock's genuinely wild recent behavior. That is the market's "expected" range, not a prediction. Moves outside that range are possible — they just need to be bigger than what the market is already pricing in.

The $40 strike sits $17 below the lower end of the implied weekly range ($57). In other words, for the put buyer to profit, AXTI would need to exceed the already-wide implied move by another $17 to the downside — a total collapse of nearly 41% from the trade-time spot in 6 days. That gives you a sense of just how extreme this bet is, even in a high-IV name.

The monthly range ($45.79 – $94.05 through July 17) does include levels where the puts would carry some value — but these puts expire July 2, not July 17. Time is the brutal enemy of far-OTM short-dated options.

---

🎪 Catalysts

🔥 Past Catalysts (Already Happened)

Q1 2026 Earnings — April 30, 2026 (Beat) 📊

AXT reported Q1 2026 results that validated the AI-optics re-rating:

• Revenue $26.9M, +39% YoY and +17% QoQ
• Non-GAAP gross margin 29.9% (vs −6.1% a year earlier)
• InP revenue $13.6M — now >50% of total revenue, more than doubled QoQ
• Record backlog >$100M

$632.5M Capital Raise — April 24, 2026

AXT priced a $632.5M public offering at $64.25/share to fund InP capacity doubling. This was a massive dilution event that inflated shares outstanding to ≈63.8M — likely contributed to the fade from $143.

June 2026 InP Supply Contract

Subsidiary Beijing Tongmei Xtal Technology signed a long-term InP-wafer supply agreement with Nanjing Casela Technologies through 2027, worth ≈RMB 173M (≈$25.4M), with an 80% minimum-purchase commitment. News hit June 22 and initially spiked the stock +12.9%.

Insider Selling into Strength

Director Jesse Chen sold 22,000 shares (≈$2.04M) June 11 and 6,172 shares (≈$711K) June 15 (Timothy Sykes) — a mild sentiment negative that contributed to the June fade.

---

📅 Upcoming Catalysts (What to Watch)

China MOFCOM InP Export Permits — Ongoing Binary (HIGHEST IMPACT) 🇨🇳

This is the single most important swing factor for AXTI. The China Ministry of Commerce export-permit regime requires a government-approved permit for each overseas InP order — processing takes ≈60 business days. Light permits cut Q4 2025 guidance by ≈20%; strong permits powered the Q1 2026 beat. A bad permit batch arriving before July 2 is the primary scenario the $40 put buyer is betting on. There is no set schedule for permit announcements — they drop without warning.

Q2 2026 Earnings — July 30, 2026 (AFTER This Trade Expires) 📊

AXT reports Q2 2026 on July 30, guided for ≈$34M revenue (contingent on permits), InP revenue >$17M, gross margin >30%, and EPS +$0.06 to +$0.08 — a return to GAAP profitability. This is a confirmed, high-magnitude catalyst — but it falls 28 days after the Jul-2 expiration. The $40 put buyer does NOT capture earnings in this trade.

InP Capacity-Doubling Milestone — End-2026

AXT plans to double InP capacity by year-end to a ≈$35M/quarter run-rate (≈$30–40M CapEx). Progress updates may come as informal commentary before the July 30 print.

Analyst Coverage

Consensus is Buy — 5 analysts, 3 Buy / 2 Hold. B. Riley raised PT to $73, maintaining Neutral. 12-month average PT ≈$86–$96.50, implying meaningful upside from current levels.

Tongmei STAR Market IPO — No Firm Date

SSE approved a STAR Market listing for subsidiary Tongmei in July 2022; the CSRC review remains unresolved. Advancement could unlock significant hidden value — but timing is uncertain.

---

🎲 Price Targets & Probabilities (Through Jul-2 Expiry)

Using the implied-move data and gamma levels as anchors for the weekly window:

📈 Bull Case (40% probability)

Target: $73–$83

AXTI holds $65 gamma support and grinds toward the $70 ceiling; a permit announcement or positive commentary pushes it through $70 and toward the weekly implied-move upper range of $82.84. Put expires worthless. The majority of daily sessions since the $143 high have shown buyers stepping in on dips to the mid-$60s, supporting this as the base-case path.

🎯 Base Case (40% probability)

Target: $60–$70 consolidation

Stock chops sideways in the $60–$70 range as the market digests the dilution and waits for the July 30 earnings catalyst. Put expires worthless. At ≈$67–$70 and with $65 as the nearest gamma support, consolidation is a natural outcome for a stock that has already shed 50%+ from its high.

📉 Bear Case (15% probability)

Target: $50–$58

A bad China permit headline, a broader momentum-selloff in AI-optics names, or a macro shock sends AXTI below $65 gamma support. The stock could test $57–$60 (the lower edge of the implied weekly range). The $40 puts would still expire worthless — at $57, you'd need another 30% drop in the remaining days.

💀 Lottery Case (<5% probability) — The Only Winning Path

Target: Below $40

A catastrophic event — an unexpected Chinese government action, a complete export-permit suspension, a major earnings pre-announcement warning, or a sector-wide meltdown — collapses AXTI more than 40% in 6 days. The stock has demonstrated this kind of volatility capability (e.g., the move from $143 to $67 over several weeks), but compressing a 40%+ drop into 6 trading days requires something truly severe. This is the only path where these puts pay off.

At expiry with AXTI at $35 (hypothetical): puts worth $5.00 each → profit ≈$4.38/contract ($5.00 − $0.62 paid) × 19,979 contracts × 100 = ≈$8.75M profit on a $1.24M investment (≈7x return).

---

💡 Trading Ideas

Fair warning before we get into this: these puts expire in 6 days at a 40%-OTM strike. Copying this exact trade is one of the highest-risk options positions that exists — it almost certainly expires worthless. The ideas below are for broader context, not a recommendation to replicate the whale trade.

🛡️ Conservative: Watch from the Sidelines

Play: Don't trade AXTI options until after July 30 earnings.

Why this works for you:

• ⏰ The binary that matters most (Q2 2026 earnings) is July 30 — which falls outside EVERY short-term expiry right now. You can't capture it cheaply.
• 💸 IV is extremely elevated, making options expensive regardless of direction
• 📊 The stock is in a post-parabolic consolidation — range-trading a volatile name without a clear near-term catalyst is coin-flip territory
• 🎯 Wait for July 30 to pass, let IV crush happen, then reassess the opportunity with cleaner data

Action plan: Set a price alert at $65 (support) and $72 (above resistance). If AXTI breaks either level with volume, you'll know which direction to research further. Then look at August or September expiry options after the post-earnings IV reset.

Risk level: Zero (cash) | Skill level: Beginner-friendly

⚖️ Balanced: Defined-Risk Put Spread (Bearish Bias, Post-Clarity)

Play: If you believe the AI-optics hype is overdone and want to express a bearish view, consider a defined-risk put spread after Q2 earnings clarity on July 30.

Structure (illustrative, after July 30):

• Buy Jul-17 $60 puts / Sell Jul-17 $50 puts — a $10-wide put spread

Why this works better than the whale trade:

• ✅ Closer-to-the-money strikes give you a realistic chance of being in-the-money if the thesis plays out
• 📊 Defined risk (max loss = net debit paid, typically $2–4 on a $10-wide spread)
• ⏰ Longer time horizon than 6 days — gives the thesis room to develop
• 💸 After earnings IV crush, options will be cheaper than they are today

Risk level: Moderate | Skill level: Intermediate

🚀 Aggressive: Speculative Put Replication (YOLO Territory — Advanced Only)

Play: If you want to speculate that AXTI has a near-term crash risk, the closest retail-accessible analog to today's whale trade would be buying a small number of out-of-the-money puts — but sized appropriately (1–5 contracts, not 20,000).

Key differences from the whale trade to keep in mind:

• 🐋 The whale has $1.2M to lose on a position they likely view as a fraction of a larger portfolio
• ❌ Replicating this at retail scale with meaningful capital concentration is a different risk profile entirely
• 💀 The probability of this specific trade paying off is under 5% — that means roughly 19 times out of 20, it expires worthless
• 🎢 The ≈18.5% implied weekly move means the options market is already pricing in substantial volatility — you need to be RIGHT and then some

Action plan: If you're determined to make this bet, buy no more than 2–5 contracts. Treat it as entertainment, not an investment. Be prepared to lose the entire premium — because you almost certainly will.

Risk level: Extreme (expect total loss of premium) | Skill level: Advanced with high risk tolerance

---

⚠️ Risk Factors

What the tape CANNOT tell us:

• 🔒 The OPRA tape does not reveal the buyer's identity, their broker, their existing AXTI position, or whether this is standalone speculation vs. a hedge on a much larger book. A $1.2M single-leg auction on a $4.4B cap name could be a retail YOLO or the tail hedge of a $100M+ long — we genuinely cannot tell.

What could make the $40 puts pay off (the real risks to AXTI longs):

• 🇨🇳 China export-permit suspension or sudden restriction. Revenue is directly gated by MOFCOM — a sudden policy change could zero out near-term revenue guidance and gap the stock 30–50% overnight. This has happened once before (the Q4 2025 guidance cut).
• 📉 Sentiment collapse on InP demand. If a tier-1 customer (Lumentum, Coherent, Broadcom) signals datacenter-capex cuts or delays in optical-transceiver orders, the InP demand story gets called into question and the ≈$4.4B valuation — built on ≈$27M quarterly revenue and barely-positive EPS — could de-rate violently.
• 💸 Dilution overhang. The April $632.5M raise at $64.25 was massive relative to AXT's revenue base. Additional capacity financing (2027 greenfield ≈$100–150M CapEx) could require more share issuance.
• 👤 Insider selling signal. Director Jesse Chen's June 2026 sales — while not alarming in isolation — warrant attention in a high-momentum name (Timothy Sykes).
• 📊 Thin gamma = no natural floor below $65. The gamma map shows thin options positioning below $65, meaning there is less dealer-driven support on the way down compared to a large-cap. If the stock breaks $65 with conviction, the next gamma levels are materially lower.

What protects AXTI bulls:

• ✅ Record >$100M InP backlog provides real revenue visibility
• ✅ ≈$25.4M Nanjing Casela contract signed June 2026 locks in long-term InP revenue with 80% minimum-purchase commitment
• ✅ Guided return to GAAP profitability in Q2 ($0.06–$0.08 EPS) signals business model is genuinely inflecting
• ✅ Merchant InP scarcity value — few credible alternative suppliers as AI optics scale
• ✅ Buy consensus with ≈$86–$96 12-month PT vs ≈$67–$70 current price implies upside from here

---

🎯 The Bottom Line

Here's the deal: Someone spent $1.2 million on a 6-day, 40%-out-of-the-money put on one of the hottest AI-semiconductor plays of 2026. That is a classic tail/crash-hedge trade — cheap premium, enormous payout if something catastrophic happens, and almost certainly expires worthless.

This trade tells us two things:

1. 📊 Downside tail risk is genuinely on people's minds for AXTI. The stock's 30x re-rating is extraordinary, but it's built on a fundamentals story that is still unfolding — and gated by a Chinese permitting process that can move revenue by 20% with no warning. Real money is paying for downside insurance even at these extreme strike distances.

2. 💡 The AI-optics re-rating has created a two-sided market. Analysts average ≈$86–$96 price targets and a buy consensus. But someone just paid $1.2M betting the stock could gap to $40. Both views are rational given the available information — which tells you how genuinely uncertain this name is.

If you own AXTI:

• ✅ The fundamental thesis (>$100M backlog, InP >50% revenue, guided profitability July 30) is intact
• 🛡️ Know your China-permit binary risk — it is the single biggest short-term threat
• 📅 Mark July 30 as the definitive catalyst date; the current ≈6-day window (through July 2) is noise relative to that event
• ⚠️ Given the ±18.5% weekly implied move, position sizing matters: use only what you can afford to see drop 30–40% in a single session

If you're on the sidelines:

• ⏰ Wait for Q2 earnings on July 30 before initiating a position — the event is too important and too close to enter blind
• 🎯 Post-earnings, if the permit story holds and GAAP profitability is confirmed, the ≈$57–$70 zone (implied weekly range floor to current) could offer a better entry
• ✅ Open vs. close — RESOLVED: next-day OPRA OI rose +19,817 (693 → 20,510), confirming an opening BTO; the position is now a real-time barometer of tail-risk sentiment

For the $40 puts specifically: Real talk — these almost always expire worthless. A 40%-OTM, 6-DTE option is a lottery ticket. The buyer almost certainly knows that and sized it accordingly. Do not read this as a confident prediction of a crash; read it as the market's way of saying "downside tail events in AXTI are not zero probability, and someone is paying $1.2M to be positioned for one."

Mark your calendars:

• ✅ June 29, 2026 (resolved): OPRA OI rose 693 → 20,510 (Δ +19,817) confirming a fresh opening BTO
• 📅 July 2, 2026 — $40 put expiration; watch final print
• 📅 July 30, 2026 — Q2 2026 earnings; the real event

---

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. The $40 Jul-2 put trade described here is far out of the money with a very short time to expiration — the overwhelming probability is that it expires worthless. The unusual trade size ($1.2M / 20,000 contracts vs. prior OI of 693) reflects an unusual options event but does not imply you should replicate the trade. Always conduct your own research and consider consulting a licensed financial advisor before making investment decisions. China export-permit dynamics create genuine binary event risk that can cause AXTI to gap materially in either direction without warning.

---

About AXT Inc: AXT Inc. (AXTI) manufactures compound semiconductor substrates — indium phosphide (InP), gallium arsenide (GaAs), and germanium (Ge) — used in optical transceivers, lasers, and photonics components for AI-datacenter connectivity, wireless infrastructure, and industrial applications. Market cap ≈$4.4B. The company has re-rated organically from ≈$1.85 (52-week low) on surging AI-optics demand and a record InP backlog, with no reverse split.

---

Last updated: June 29, 2026 — morning OI check confirmed an opening BTO: OI 693 → 20,510 (Δ +19,817). No inversion.